Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 1286 (MIR1286) is a short, non-coding RNA gene in humans that encodes a microRNA—a small (20–24 nucleotides) regulatory RNA molecule that modulates gene expression post-transcriptionally. Like other microRNAs, MIR1286 is transcribed as part of a longer primary transcript, processed by Drosha and Dicer enzymes, and incorporated into the RNA-induced silencing complex (RISC), which binds to target mRNAs to inhibit their translation or promote degradation. MIR1286 has been associated with the inhibition of osteogenic differentiation via targeting of FZD4 expression, which may contribute to the progression of osteoporosis. There is currently no evidence that MIR1286 is a therapeutic target, receptor, enzyme, transporter, or conventional drug target. Its medical significance is under investigation, and no drugs are known to specifically target MIR1286.
microRNAs generally act through incorporation into RNA-induced silencing complex (RISC) to inhibit or degrade target mRNAs, but specific drug mechanisms for MIR1286 have not been described
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 1286 (MIR1286).